Epigral Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 16%)
- Efficient capital deployment (ROCE 15.5%)
- Attractively valued vs sector (P/E 14.2x vs industry 37x)
- Low debt relative to equity (D/E 0.3x)
- Near 52-week low — potential value zone (₹806)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SOLARINDS Solar Industries India Limited | ₹19,240 | ₹1.7L Cr | 83.4 | 27.72 | 32.6 | 38.1 | 0.17 |
| PIDILITIND Pidilite Industries Limited | ₹1,390 | ₹1.5L Cr | 57.2 | 13.11 | 23.9 | 31 | 0.05 |
| SRF SRF Limited | ₹2,350 | ₹68K Cr | 29 | 4.55 | 14.3 | 14.6 | 0.35 |
| COROMANDEL Coromandel International Limited | ₹— | ₹51K Cr | 27.1 | 4.12 | 16.4 | 22 | 0.11 |
| LINDEINDIA Linde India Limited | ₹— | ₹49K Cr | 89.3 | 15.49 | 13.6 | 18.2 | 0.02 |
| FLUOROCHEM Gujarat Fluorochemicals Limited | ₹— | ₹47K Cr | 75.3 | 5.25 | 7.82 | 9.64 | 0.29 |
| FACT Fertilizers and Chemicals Travancore Limited | ₹— | ₹43K Cr | 2,930 | 41 | 1.61 | 8.65 | 2.79 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
EPIGRAL · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 71.38% | 71.49% | 71.58% | 71.58% | 68.94% | 68.95% |
| FII | 1.17% | 1.36% | 1.46% | 2.10% | 3.01% | 3.01% |
| DII | 0.05% | 0.02% | 0.18% | 1.17% | 4.31% | 4.66% |
| Public | 27.37% | 27.10% | 26.75% | 25.12% | 23.71% | 23.34% |
| Govt | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
Latest News
All newsEpigral to discuss Q2 FY27 results with investors
*Epigral to discuss Q2 FY27 results with investors* as part of an analyst and institutional investor meet scheduled for 2nd November, 2026. The session will provide insights into the company's performance and outlook. No new financial figures or guidance were disclosed in the filing. The event is primarily informational for market participants. 📊 *STOCKS:* $EPIGRAL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Earnings
Epigral hosts investor meet and plant visit on Oct 22, 2026
*Epigral hosts investor meet and plant visit on Oct 22, 2026.* The company is conducting an analyst and institutional investor plant visit. This event aims to enhance investor engagement and provide operational insights. Such visits may improve transparency but lack immediate financial triggers. 📊 *STOCKS:* $EPIGRAL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Epigral holds annual general meeting; voting results disclosed
*Epigral holds annual general meeting; voting results disclosed* — Epigral Limited has submitted the scrutinizer’s report of its Annual General Meeting held on **Jun 08, 2026**, to the NSE, including voting outcomes. The filing is part of mandatory disclosure requirements. No material business decisions or financial updates were announced. Routine corporate formalities completed. 📊 *STOCKS:* EPIGRAL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateFiling
About Epigral Limited
Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.
ChemicalsChemicals & Petrochemicals